CPT code 89254 covers the laboratory technical procedure to analyze follicular fluid for the presence of oocytes. The code is central to assisted reproductive technology (ART) workflows, including in vitro fertilization (IVF) cycles, where accurate identification of eggs in retrieved follicular fluid is essential for subsequent embryology procedures. Nationally, consistent coding for oocyte identification supports clinical documentation, laboratory quality control, and appropriate billing across fertility programs.

This analysis discusses coverage and coding considerations for major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for 89254, typical sites where the service is performed, and which payers commonly address coverage for ART laboratory services. The publication also outlines benchmarks and policy-relevant topics that affect laboratory billing for reproductive services, such as bundling practices, documentation expectations, and common modifier usage.

The report is intended to help clinical managers, billing staff, and policy analysts understand where 89254 fits in ART laboratory workflows, how payers approach coverage at a national level, and what operational and coding elements are important when reporting this technical laboratory service.